SpaceX IPO

Markets are bracing for volatility amid escalating geopolitical tensions, particularly President Trump’s stern remarks on Iran, which sent oil prices soaring and stock futures tumbling. SpaceX has confidentially filed for an IPO, potentially valuing the company at $1.75 trillion. Congress is moving towards a bipartisan Homeland Security funding deal. Eli Lilly’s new GLP-1 weight loss pill, Foundayo, received FDA approval, intensifying competition. Sam’s Club will increase membership fees by $10 next month.

The potential SpaceX IPO is energizing the space sector, with shares of AST SpaceMobile, Rocket Lab, and Firefly Aerospace seeing significant gains. This rally is fueled by technological ambition, national security interests, and the growing demand for AI infrastructure, including the novel concept of space-based data centers. The rumored $75 billion valuation for SpaceX underscores investor confidence in its transformative projects.

xAI, Elon Musk’s AI venture, faces significant co-founder departures, including key researchers Ba and Wu. This exodus occurs as xAI integrates with SpaceX, valued at $1 trillion, and faces regulatory probes in multiple regions over deepfake content generated by its Grok AI. Despite its ambitious goals to rival OpenAI and Google, these internal and external challenges raise questions about xAI’s stability and future.